Trials / Completed
CompletedNCT00349128
Fenofibrate in Dyslipidemia and Metformin-Controlled Diabetes
A Randomized, Double-Blind Trial Assessing the Efficacy and Safety of Low and Standard Doses of Fenofibrate in Combination With Metformin on the Lipid Profile in Patients With Type 2 Diabetes and Dyslipidemia.
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 382 (planned)
- Sponsor
- Solvay Pharmaceuticals · Industry
- Sex
- All
- Age
- 20 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective was to assess the effect of 3-month treatment of low and standard doses of fenofibrate in combination with stable dose of metformin on fasting triglycerides levels in patients with type 2 diabetes and dyslipidemia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | fenofibrate and metformin combination (drug) |
Timeline
- Start date
- 2004-01-01
- First posted
- 2006-07-06
- Last updated
- 2007-09-03
Locations
51 sites across 3 countries: Poland, Ukraine, United Kingdom
Source: ClinicalTrials.gov record NCT00349128. Inclusion in this directory is not an endorsement.